More Business Briefs
- Business briefs: Novo Nordisk, Eli Lilly, Merck
- Business briefs: Medscape, Livestrong, ACA, Lilly
- Business briefs: Boehringer Ingelheim, Teva, Medicare
- Business briefs: GSK, DOJ, Sanofi, Flashpoint Medica
- Business briefs: Aveo, Dynavax, Gilead, OPDP
Japanese pharma giants are taking stock of the damage from last Friday's Tohoku Earthquake and tsunami. Tokyo-based Daiichi Sankyo said all its employees were safe and accounted for, though a few had suffered minor injuries. The company said two plants were partly damaged by the earthquake, and sales and marketing activities at several branches in hard-hit areas had been halted. Astellas, also based in Tokyo, said it had confirmed that all of its and its affiliates' employees were safe, but that operations at two manufacturing plants and a chemistry lab had been halted and marketing employees based in devastated regions instructed to remain on standby at home. Osaka-based Takeda announced it would donate 300 million yen and pharmaceutical products to relief efforts.
The pharmaceutical industry ranked well in The National Association of Female Executives' annual list of the top 50 companies for female executives. Among the companies that made the list were Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, J&J, Merck and Pfizer.